CAROL KING: Open Payments
NPI 1184914962 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 57 payments from 29 companies in 2025. Trend: 2023 $1,634 · 2024 $1,137 · 2025 $1,272
Food & beverage: $1,272
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $224 |
| ABBVIE INC. | 9 | $170 |
| Novo Nordisk Inc | 8 | $154 |
| Lilly USA, LLC | 1 | $100 |
| Lundbeck LLC | 3 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Shockwave Medical, Inc | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Dexcom, Inc. | 2 | $32 |
Products named: REXULTI, QULIPTA, ZEPBOUND, VRAYLAR, JOURNAVX, Wegovy, Kerendia, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter.
Industry payments across TX — which companies pay providers there.
